Skip to main content

Anant Madabhushi

NIH Rank #2013
  • Program Leader
  • R01 Holder
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8352708Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • OTHER BASIC SCIENCES
  • ENGINEERING (ALL TYPES)
  • Biomedical Engineering

NIH Funding · FY2024

Linked Award Amount
$3.5M
Full award amounts, FY2024
Award Records
7
Records listing this PI
Award-Linked Rank
#2,013
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Anant Madabhushi. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Anant Madabhushi as a PI. Multi-PI records show the full award amount for context.

  • 5R01HL158071-04R01
    RADIOMIC APPROACHES TO IMPROVE TARGETING FOR ATRIAL FIBRILLATION CATHETER ABLATION
    $716.1K
    award amount
  • 5R01CA268207-03R01
    Prostate cancer risk stratification via computational 3D pathology
    $598.3K
    award amount
  • 5R01CA249992-04R01
    Oral Cavity Quantitative Histomorphometric Risk Classifier (OHbIC) in Oral Cavity Squamous Cell Carcinoma (OC-SCC)
    $580.1K
    award amount
  • 5R01CA257612-04R01
    Novel Radiomics for Predicting Response to Immunotherapy for Lung Cancer
    $506.6K
    award amount
  • 5R01CA268287-03R01
    Prognostic and Predictive Digital Tissue Image Assay for Prostate Cancer
    $476.2K
    award amount
  • 5U01CA269181-03U01
    An AI-enabled Digital Pathology Platform for Multi-Cancer Diagnosis, Prognosis and Prediction of Therapeutic Benefit
    $379.3K
    award amount
  • 5U54CA254566-05U54
    Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging
    $255.6K
    award amount

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Emory University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2013
  6. 2024
    Entered Top 25% Nationally
    Ranked #2013
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Multi-Institutional Research
    Awards at 4 institutions
  9. 2025
    R01 Grant Holder
  10. 2025
    Program/Center Grant Leader
  11. 2026
    $10M Cumulative Funding
  12. 2026
    Entered Top 10% Nationally
    Ranked #1457